Paper · 322689

Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.

Powles RL and 8 others. Br J Cancer, 1977. Cited by 99 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. Papers, record 322689. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/322689

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient.; PubMed
Journal: Br J Cancer; PubMed
Year: 1977; PubMed
Publication types: Clinical Trial, Journal Article, Randomized Controlled Trial; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/322689/; PubMed
DOI: https://doi.org/10.1038/bjc.1977.38; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC2025283/; PubMed
The journal: https://conductscience.org/library/journal-index/0370635; PubMed
Citations, by iCite: 99; iCite
Relative citation ratio, by iCite: 2.35; iCite
Revised in PubMed: 2019-05-15; PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Powles RL	R L
2	Russell J	J
3	Lister TA	T A
4	Oliver T	T
5	Whitehouse JM	J M
6	Malpas J	J
7	Chapuis B	B
8	Crowther D	D
9	Alexander P	P

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
BCG Vaccine	Major topic
Leukemia, Myeloid, Acute	Major topic
Adolescent
Adult
Aged
Clinical Trials as Topic
Female
Humans
Male
Middle Aged
Prognosis
Remission, Spontaneous
Time Factors

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References15

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	14,102,244	AN IMMUNOLOGICAL METHOD OF INCREASING THE SENSITIVITY OF PRIMARY SARCOMAS TO LOCAL IRRADIATION WITH X RAYS.	Lancet	1964	https://conductscience.org/library/papers/14102244	PubMed
2	4,140,327	Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.	Lancet	1974	https://conductscience.org/library/papers/4140327	PubMed
3	4,135,502	Prolonging remission in myeloblastic leukemia by tice-strain bacillus Calmette-Guérin.	Lancet	1974	https://conductscience.org/library/papers/4135502	PubMed
4	4,393,524	The role of immunoblasts in host resistance and immunotherapy of primary sarcomata.	Adv Cancer Res	1970	https://conductscience.org/library/papers/4393524	PubMed
5	4,270,730	Some properties of cryopreserved acute leukemia cells.	Cryobiology	1973	https://conductscience.org/library/papers/4270730	PubMed
6	4,271,320	Immunotherapy for acute myelogenous leukaemia.	Br J Cancer	1973	https://conductscience.org/library/papers/4271320	PubMed
7	48,643	Letter: Chemoimmunotherapy of adult acute leukaemia.	Lancet	1975	https://conductscience.org/library/papers/48643	PubMed
8	4,513,355	Management of adult acute myelogenous leukaemia.	Br Med J	1973	https://conductscience.org/library/papers/4513355	PubMed
9	4,519,012	Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.	Br Med J	1973	https://conductscience.org/library/papers/4519012	PubMed
10	4,529,647	Safe method of collecting leukaemia cells from patients with acute leukaemia for use as immunotherapy.	Br Med J	1974	https://conductscience.org/library/papers/4529647	PubMed

1 to 10 of 15

See all 15 references

Cited by34

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 99 citations.

PMID	Title	Journal	Year	In Papers	Source
38,576,381	NCAPD3 is a prognostic biomarker and is correlated with immune infiltrates in glioma.	Histol Histopathol	2024	https://conductscience.org/library/papers/38576381	PubMed
36,052,072	Advanced Cell Therapies for Glioblastoma.	Front Immunol	2022	https://conductscience.org/library/papers/36052072	PubMed
35,074,008	Research progress on dendritic cell vaccines in cancer immunotherapy.	Exp Hematol Oncol	2022	https://conductscience.org/library/papers/35074008	PubMed
34,639,025	Trained Immunity as an Adaptive Branch of Innate Immunity.	Int J Mol Sci	2021	https://conductscience.org/library/papers/34639025	PubMed
30,957,058	Systemic Immunotherapy Effective for Refractory Extramedullary Acute Myeloid Leukemia.	JCO Precis Oncol	2019	https://conductscience.org/library/papers/30957058	PubMed
21,519,825	Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia.	Cancer Immunol Immunother	2011	https://conductscience.org/library/papers/21519825	PubMed
20,529,084	Immunotherapy prospects for acute myeloid leukaemia.	Clin Exp Immunol	2010	https://conductscience.org/library/papers/20529084	PubMed
18,342,811	Is it important to decipher the heterogeneity of "normal karyotype AML"?	Best Pract Res Clin Haematol	2008	https://conductscience.org/library/papers/18342811	PubMed
17,437,417	Translational mini-review series on vaccines: Peptide vaccines for myeloid leukaemias.	Clin Exp Immunol	2007	https://conductscience.org/library/papers/17437417	PubMed
17,254,347	Therapeutic use of Aldara in chronic myeloid leukemia.	J Transl Med	2007	https://conductscience.org/library/papers/17254347	PubMed

1 to 10 of 34

See all 34 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/322689

GET https://conductscience.org/api/papers/v1/322689/cited_by?page=2

API reference For AI assistants